TY  - JOUR
AU  - Idahl, Annika
AU  - Cornet, Charlotte Le
AU  - Maldonado, Sandra González
AU  - Waterboer, Tim
AU  - Bender, Noemi
AU  - Tjønneland, Anne
AU  - Hansen, Louise
AU  - Boutron-Ruault, Marie-Christine
AU  - Fournier, Agnès
AU  - Kvaskoff, Marina
AU  - Boeing, Heiner
AU  - Trichopoulou, Antonia
AU  - Valanou, Elisavet
AU  - Peppa, Eleni
AU  - Palli, Domenico
AU  - Agnoli, Claudia
AU  - Mattiello, Amalia
AU  - Tumino, Rosario
AU  - Sacerdote, Carlotta
AU  - Onland-Moret, N Charlotte
AU  - Gram, Inger T
AU  - Weiderpass, Elisabete
AU  - Quirós, J Ramón
AU  - Duell, Eric J
AU  - Sánchez, Maria-Jose
AU  - Chirlaque, Maria-Dolores
AU  - Barricarte, Aurelio
AU  - Gil, Leire
AU  - Brändstedt, Jenny
AU  - Riesbeck, Kristian
AU  - Lundin, Eva
AU  - Khaw, Kay-Tee
AU  - Perez-Cornago, Aurora
AU  - Gunter, Marc J
AU  - Dossus, Laure
AU  - Kaaks, Rudolf
AU  - Turzanski-Fortner, Renée
TI  - Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort.
JO  - International journal of cancer
VL  - 147
IS  - 8
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2020-00747
SP  - 2042-2052
PY  - 2020
N1  - 147(8):2042-2052#LA:C020#
AB  - A substantial proportion of epithelial ovarian cancer (EOC) arises in the fallopian tube and other epithelia of the upper genital tract; these epithelia may incur damage and neoplastic transformation following sexually transmitted infections (STI) and pelvic inflammatory disease. We investigated the hypothesis that past STI infection, particularly Chlamydia trachomatis, is associated with higher EOC risk in a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort including 791 cases and 1,669 matched controls. Serum antibodies against C. trachomatis, Mycoplasma genitalium, herpes simplex virus type 2 (HSV-2) and human papillomavirus (HPV) 16, 18 and 45 were assessed using multiplex fluorescent bead-based serology. Conditional logistic regression was used to estimate relative risks (RR) and 95
LB  - PUB:(DE-HGF)16
C6  - pmid:32243586
DO  - DOI:10.1002/ijc.32999
UR  - https://inrepo02.dkfz.de/record/154416
ER  -